SML3843
BAY-985
≥98% (HPLC)
Synonym(s):
(R)-1-(4-(1-(2-(6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one, 1-(4-{(1R)-1-[2-({6-[6-(Dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl}amino)-pyridin-4-yl]ethyl}piperazin-1-yl)-3,3,3-trifluoropropan-1-one, BAY 985, BAY985
Select a Size
About This Item
InChI
1S/C27H30F3N9O/c1-17(38-8-10-39(11-9-38)25(40)15-27(28,29)30)18-6-7-31-23(13-18)36-26-34-20-5-4-19(12-22(20)35-26)21-14-24(37(2)3)33-16-32-21/h4-7,12-14,16-17H,8-11,15H2,1-3H3,(H2,31,34,35,36)/t17-/m1/s1
InChI key
HZRJHVDNTDBTOZ-QGZVFWFLSA-N
SMILES string
O=C(CC(F)(F)F)N1CCN(CC1)[C@H](C)C2=CC(NC3=NC4=CC=C(C=C4N3)C5=NC=NC(N(C)C)=C5)=NC=C2
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Related Categories
Biochem/physiol Actions
BAY-985 is an ATP-competitive, potent and selective inhibitor against IκB kinase members TANK-binding kinase 1 (TBK1 IC50 = 2/30 nM with 10 μM/1 mM ATP) and IKK-epsilon (IKKε IC50 = 2 nM with 10 μM ATP) with 60-, 138-, 155, and ~4000-fold lower potency toward FLT3, RSK4, DRAK1, and ULK1, respectively. BAY-985 potently inhibits cellular interferon regulatory factor 3 phosphorylation (pIRF3 IC50 = 74 nM) and displays antiproliferation efficacy in human melanoma SK-MEL-2 cultures (IC50 = 900 nM). When administered orally (200 mg/kg bid. po.), BAY-985 suppresses SK-MEL-2 xengraft-derived tumor growth in mice in vivo (T/C tumor weight ratio = 0.6).
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service